Nimacimab shows comparable weight loss to monlunabant and tirzepatide alone, and an additive effect in combination with tirzepatide, in diet-induced obesity model New in vitro data demonstrates superior potency of nimacimab’s differentiated and favorable mechanism of inhibition […]
Kuala Lumpur, Malaysia, April 14, 2025 — ARB IOT Group Limited (“ARB IOT” or the “Company”) (NASDAQ: ARBB) today announced that it has, through its indirect wholly owned subsidiary, ARB R1 Technology Sdn Bhd, successfully […]
Successful robotic navigation was achieved in every case and met the primary endpoint of the study LIBERTY® showed a 92% reduction in radiation exposure with no adverse events reported HINGHAM, Mass., April 09, 2025 — Microbot Medical […]
RONKONKOMA, N.Y., April 09, 2025 — SUNation Energy, Inc. (Nasdaq: SUNE) (“SUNation” or “the Company”), a leading provider of sustainable solar energy and backup power solutions for households, businesses, and municipalities, today announced that recently […]
Continued Clear Visual Evidence of Almost Completely Healed Skin After 6 weeks Treatment High Durability of Treatment Effect of QRX003 with Continuous Daily Dosing Patient Continues Not to Require Previously Necessary Medications With Patient’s Pruritus […]
Republic National Distribution Company opens new distribution channels in six states including California, one of the largest markets in the U.S. SEVEN HILLS, AU April 2, 2025 / Innovation Beverage Group Ltd (“IBG” or the “Company”) […]
Company successfully developed predictive models derived from 21 unique compounds from the Natural Products Discovery Core at the University of Michigan Tumor response models for novel compounds represent true drug discovery using Predictive’s active machine learning […]
~ Achieves Significant Milestone with Expanded Use Indication, Opens Sizable New SI Market Opportunity ~ LOS GATOS, CA / March 24, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) (“Tenon” or the “Company”), a company transforming care […]
Transaction Strengthens Balance Sheet and Enables Execution of Multi-Vertical Revenue Strategy VANCOUVER, BC, March 21, 2025 /PRNewswire/ – Damon Inc. (NASDAQ: DMN) (“Damon” or the “Company”), a designer and developer of electric motorcycles and other personal mobility […]
Collaboration aims to make portable MRI faster, smarter, and more accessible worldwide. GUILFORD, Conn., March 17, 2025—-Hyperfine, Inc. (NASDAQ: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered […]
Seventh Generation of Industry-Leading Exoskeleton Includes New and Enhanced Features for Individuals with Spinal Cord Injury MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 13, 2025 — Lifeward Ltd., (NASDAQ: LFWD) (“Lifeward” or the “Company”), a […]
Programs to be Driven Through Patented AI Technology and Advanced Proprietary B Cell Platforms Partnership advances next-generation ADCs and bispecific antibodies to address unmet medical needs AUSTIN, Texas, March 13, 2025—ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: […]
HOUSTON, March 06, 2025 — Plus Therapeutics, Inc. (NASDAQ: PSTV) (the “Company” or “Plus Therapeutics”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, today announces that the […]
FDA concludes site inspection is closed under 21 C.F.R.20.64(d)(3); Voluntary Action Indicated Company believes this further supports reliability of data from TRANQUILITY II trial of BXCL501 NEW HAVEN, Conn., March 03, 2025 — BioXcel Therapeutics, […]
– The Company today reported positive initial results from the ongoing FREEDOM-DM1 trial in patients with DM1; mean splicing correction of 12.3% and 29.1% in 5 and 10 mg/kg cohorts, respectively – – FREEDOM-DM1 15 […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
